| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.15▲ | 3.15▲ | 3.14▲ | 3.10▲ | 3.02▲ |
| MA10 | 3.15▲ | 3.14▲ | 3.15▲ | 3.04▲ | 2.98▲ |
| MA20 | 3.15▲ | 3.15▲ | 3.14▲ | 3.02▲ | 2.94▲ |
| MA50 | 3.14▲ | 3.14▲ | 3.09▲ | 2.96▲ | 3.68▼ |
| MA100 | 3.15▲ | 3.08▲ | 3.04▲ | 2.98▲ | 4.79▼ |
| MA200 | 3.14▲ | 3.04▲ | 2.97▲ | 3.68▼ | 6.02▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.000▼ | -0.005▼ | 0.018▲ | 0.084▲ |
| RSI | 55.854▲ | 53.197▲ | 55.056▲ | 57.088▲ | 48.810▼ |
| STOCH | 54.545 | 60.393 | 38.667 | 68.275 | 46.532 |
| WILL %R | -41.667 | -39.130 | -44.000 | -22.500▲ | -30.128 |
| CCI | 46.154 | 93.114 | 3.315 | 106.276▲ | 98.743 |
|
Wednesday, August 05, 2026 01:00 AM
GAITHERSBURG, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today ...
|
|
Wednesday, June 17, 2026 08:15 AM
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
|
|
Wednesday, June 17, 2026 04:16 AM
Altimmune, Inc. (NASDAQ:ALT) is one of the small-cap stocks with potential to rise 1000 percent. The company’s lead drug candidate, pemvidutide, is being developed for MASH, a serious liver disease ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 26/08/26 | 3.19 | 3.19 | 3.09 | 3.15 | 4,044,934 |
| 25/08/26 | 3.14 | 3.225 | 3.11 | 3.20 | 3,801,301 |
| 24/08/26 | 3.13 | 3.13 | 3.03 | 3.11 | 2,261,204 |
| 21/08/26 | 2.98 | 3.24 | 2.95 | 3.11 | 6,147,904 |
| 20/08/26 | 3.07 | 3.08 | 2.92 | 2.95 | 4,679,681 |
| 19/08/26 | 3.05 | 3.20 | 3.005 | 3.12 | 10,737,895 |
| 18/08/26 | 2.99 | 3.03 | 2.96 | 2.97 | 2,402,651 |
| 17/08/26 | 2.94 | 3.02 | 2.90 | 3.00 | 3,963,545 |
| 14/08/26 | 2.94 | 2.97 | 2.86 | 2.94 | 2,966,426 |
| 13/08/26 | 2.95 | 2.96 | 2.84 | 2.88 | 3,875,750 |
|
|
||||
|
|
||||
|
|